Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CollPlant Biotechnologies Ltd. - Ordinary Shares (NQ:CLGN)

2.100 +0.070 (+3.45%)
Streaming Delayed Price Updated: 1:23 PM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CollPlant Biotechnologies Ltd. - Ordinary Shares

< Previous 1 2 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Down 100 Points; Chicago PMI Dips In May
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Preview: CollPlant Biotechnologies
Via Benzinga
CollPlant Biotechnologies's Earnings: A Preview
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Via Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Recap: CollPlant Biotechnologies Q3 Earnings
Via Benzinga
Earnings Outlook For CollPlant Biotechnologies
Via Benzinga
Preview: CollPlant Biotechnologies's Earnings
Via Benzinga
Earnings Scheduled For May 28, 2025
Via Benzinga
Earnings Scheduled For March 26, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 27, 2024
Via Benzinga
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024
CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024
CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For April 4, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. 
Via Benzinga
Earnings Scheduled For November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why CollPlant Biotechnologies Stock Is Trading Higher
CollPlant Biotechnologies Ltd (NASDAQ: CLGN) shares are trading higher Monday after the company announced it achieved a milestone in its product collaboration agreement with AbbVie Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.